The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Gender Differences in Patients With COVID-19: Focus on Severity and Mortality
Open accessPublished version of a preprint
Abstract
Abstract Importance The recent outbreak of Novel Coronavirus (SARS-CoV-2) Disease (COVID-19) has put the world on alert, that is reminiscent of the SARS outbreak seventeen years ago. Objective We aim to compare the severity and mortality between male and female patients with both COVID-19 and SARS, to explore the most useful prognostic factors for individualized assessment. Design, Setting, and Participants We extracted the data from a case series of 43 hospitalized patients we treated, a public data set of the first 37 cases died of COVID-19 in Wuhan city and 1019 survived patients from six cities in China. We also analyzed the data of 524 patients with SARS, including 139 deaths, from Beijing city in early 2003. Main Outcomes and Measures Severity and mortality. Results Older age and high number of comorbidities were associated with higher severity and mortality in patients with both COVID-19 and SARS. The percentages of older age (≥65 years) were much higher in the deceased group than in the survived group in patients with both COVID-19 (83.8 vs. 13.2, P<0.001) and SARS (37.4 vs. 4.9, P<0.001). In the case series, men tend to be more serious than women (P=0.035), although age was comparable between men and women. In the public data set, age was also comparable between men and women in the deceased group or the survived group in patients with COVID-19. Meanwhile, gender distribution was exactly symmetrical in the 1019 survivors of COVID-19. However, the percentage of male were higher in the deceased group than in the survived group (70.3 vs. 50.0, P=0.015). The gender role in mortality was also observed in SARS patients. Survival analysis showed that men (hazard ratio [95% CI] 1.47 [1.05-2.06, P= 0.025) had a significantly higher mortality rate than women in patients with SARS. Conclusions and Relevance Older age and male gender are risk factors for worse outcome in patients with COVID. While men and women have the same susceptibility to both SARS-CoV-2 and SARS-CoV, men may be more prone to have higher severity and mortality independent of age and susceptibility. Key Points Question Are men more susceptible to getting and dying from COVID-19? Findings In the case series, men tend to be more serious than women. In the public data set, the percentage of men were higher in the deceased group than in the survived group, although age was comparable between men and women. Meaning Male gender is a risk factor for worse outcome in patients with COVID independent of age and susceptibility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
Self-citationLa certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
Self-citationIsolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
Drosten, C., Günther, S., Preiser, W., van der Werf, S., Brodt, H.-R., Becker, S., Rabenau, H., Panning, M., Kolesnikova, L., Fouchier, R. A. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030747 · Cited by 4,574
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yang, Y.-B., Yan, Y.-Q., Akdis, C. A., & Gao, Y.-D. (2020) · Allergy · doi:10.1111/all.14238 · Cited by 4,004
Research works printed but not linked: 1
- Jin, 2020, Gender differences in patients with COVID-19: focus on severity and mortality, medRxiv [Preprint], 10.1101/2020.02.23.20026864 · DOI
Cited by
COVID-19 pathophysiology: A review
Yuki, K., Fujiogi, M., & Koutsogiannaki, S. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108427 · Cited by 2,206
Risk perceptions of COVID-19 around the world
Dryhurst, S., Schneider, C. R., Kerr, J., Freeman, A. L. J., Recchia, G., van der Bles, A. M., Spiegelhalter, D., & van der Linden, S. (2020) · Journal of Risk Research · doi:10.1080/13669877.2020.1758193 · Cited by 1,809
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
Peckham, H., de Gruijter, N. M., Raine, C., Radziszewska, A., Ciurtin, C., Wedderburn, L. R., Rosser, E. C., Webb, K., & Deakin, C. T. (2020) · Nature Communications · doi:10.1038/s41467-020-19741-6 · Cited by 1,503
Age-specific mortality and immunity patterns of SARS-CoV-2
O’Driscoll, M., Ribeiro Dos Santos, G., Wang, L., Cummings, D. A. T., Azman, A. S., Paireau, J., Fontanet, A., Cauchemez, S., & Salje, H. (2021) · Nature · doi:10.1038/s41586-020-2918-0 · Cited by 1,210
Dietary Choices and Habits during COVID-19 Lockdown: Experience from Poland
Sidor, A., & Rzymski, P. (2020) · Nutrients · doi:10.3390/nu12061657 · Cited by 1,111
Non-adherence to COVID-19 containment behaviours: results from an all-Ireland telephone survey
Dempster, M., O’Connell, N., Graham, C. D., O’Connor, C., Zgaga, L., Burke, E., Mather, L., Nicolson, G., Barry, J., Scally, G., et al. (2022) · BMC Public Health · doi:10.1186/s12889-022-13322-6 · Cited by 1,070
Considering how biological sex impacts immune responses and COVID-19 outcomes
Scully, E. P., Haverfield, J., Ursin, R. L., Tannenbaum, C., & Klein, S. L. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0348-8 · Cited by 932
Izcovich, A., Ragusa, M. A., Tortosa, F., Lavena Marzio, M. A., Agnoletti, C., Bengolea, A., Ceirano, A., Espinosa, F., Saavedra, E., Sanguine, V., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0241955 · Cited by 660
Pijls, B. G., Jolani, S., Atherley, A., Derckx, R. T., Dijkstra, J. I. R., Franssen, G. H. L., Hendriks, S., Richters, A., Venemans-Jellema, A., Zalpuri, S., et al. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044640 · Cited by 586
SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
Poland, G. A., Ovsyannikova, I. G., & Kennedy, R. B. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32137-1 · Cited by 572
Association Between Hypoxemia and Mortality in Patients With COVID-19
Xie, J., Covassin, N., Fan, Z., Singh, P., Gao, W., Li, G., Kara, T., & Somers, V. K. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.04.006 · Cited by 566
Machine learning-based prediction of COVID-19 diagnosis based on symptoms
Zoabi, Y., Deri-Rozov, S., & Shomron, N. (2021) · npj Digital Medicine · doi:10.1038/s41746-020-00372-6 · Cited by 523
Risk factors for Covid-19 severity and fatality: a structured literature review
Wolff, D., Nee, S., Hickey, N. S., & Marschollek, M. (2021) · Infection · doi:10.1007/s15010-020-01509-1 · Cited by 511
A population-based cohort study of socio-demographic risk factors for COVID-19 deaths in Sweden
Drefahl, S., Wallace, M., Mussino, E., Aradhya, S., Kolk, M., Brandén, M., Malmberg, B., & Andersson, G. (2020) · Nature Communications · doi:10.1038/s41467-020-18926-3 · Cited by 450
Asselta, R., Paraboschi, E. M., Mantovani, A., & Duga, S. (2020) · Aging · doi:10.18632/aging.103415 · Cited by 422
COVID-19 and the elderly: insights into pathogenesis and clinical decision-making
Perrotta, F., Corbi, G., Mazzeo, G., Boccia, M., Aronne, L., D’Agnano, V., Komici, K., Mazzarella, G., Parrella, R., & Bianco, A. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01631-y · Cited by 420
Abu-Rumeileh, S., Abdelhak, A., Foschi, M., Tumani, H., & Otto, M. (2021) · Journal of Neurology · doi:10.1007/s00415-020-10124-x · Cited by 419
Wong, S. Y. S., Zhang, D., Sit, R. W. S., Yip, B. H. K., Chung, R. Y.-N., Wong, C. K. M., Chan, D. C. C., Sun, W., Kwok, K. O., & Mercer, S. W. (2020) · British Journal of General Practice · doi:10.3399/bjgp20x713021 · Cited by 409
Janssen, M., Chang, B. P. I., Hristov, H., Pravst, I., Profeta, A., & Millard, J. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.635859 · Cited by 395
Coroiu, A., Moran, C., Campbell, T., & Geller, A. C. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239795 · Cited by 368
Garvin, M. R., Alvarez, C., Miller, J. I., Prates, E. T., Walker, A. M., Amos, B. K., Mast, A. E., Justice, A., Aronow, B., & Jacobson, D. (2020) · eLife · doi:10.7554/elife.59177 · Cited by 361
Gharbharan, A., Jordans, C. C. E., GeurtsvanKessel, C., den Hollander, J. G., Karim, F., Mollema, F. P. N., Stalenhoef – Schukken, J. E., Dofferhoff, A., Ludwig, I., Koster, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23469-2 · Cited by 347
Bienvenu, L. A., Noonan, J., Wang, X., & Peter, K. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa284 · Cited by 338
Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions
Ali, S. T., Wang, L., Lau, E. H. Y., Xu, X.-K., Du, Z., Wu, Y., Leung, G. M., & Cowling, B. J. (2020) · Science · doi:10.1126/science.abc9004 · Cited by 331
Years of life lost to COVID-19 in 81 countries
Pifarré i Arolas, H., Acosta, E., López-Casasnovas, G., Lo, A., Nicodemo, C., Riffe, T., & Myrskylä, M. (2021) · Scientific Reports · doi:10.1038/s41598-021-83040-3 · Cited by 312
Persistence of symptoms and quality of life at 35 days after hospitalization for COVID-19 infection
Jacobs, L. G., Gourna Paleoudis, E., Lesky-Di Bari, D., Nyirenda, T., Friedman, T., Gupta, A., Rasouli, L., Zetkulic, M., Balani, B., Ogedegbe, C., et al. (2020) · PLOS ONE · doi:10.1371/journal.pone.0243882 · Cited by 321
Senolytics reduce coronavirus-related mortality in old mice
Camell, C. D., Yousefzadeh, M. J., Zhu, Y., Prata, L. G. P. L., Huggins, M. A., Pierson, M., Zhang, L., O’Kelly, R. D., Pirtskhalava, T., Xun, P., et al. (2021) · Science · doi:10.1126/science.abe4832 · Cited by 320
Racial and Gender-Based Differences in COVID-19
Kopel, J., Perisetti, A., Roghani, A., Aziz, M., Gajendran, M., & Goyal, H. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00418 · Cited by 313
Sex differences in severity and mortality from COVID-19: are males more vulnerable?
Pradhan, A., & Olsson, P.-E. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00330-7 · Cited by 313
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
Rodríguez, Y., Novelli, L., Rojas, M., De Santis, M., Acosta-Ampudia, Y., Monsalve, D. M., Ramírez-Santana, C., Costanzo, A., Ridgway, W. M., Ansari, A. A., et al. (2020) · Journal of Autoimmunity · doi:10.1016/j.jaut.2020.102506 · Cited by 312
Bryche, B., St Albin, A., Murri, S., Lacôte, S., Pulido, C., Ar Gouilh, M., Lesellier, S., Servat, A., Wasniewski, M., Picard-Meyer, E., et al. (2020) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.06.032 · Cited by 307
Fernández-de-las-Peñas, C., Martín-Guerrero, J. D., Pellicer-Valero, Ó. J., Navarro-Pardo, E., Gómez-Mayordomo, V., Cuadrado, M. L., Arias-Navalón, J. A., Cigarán-Méndez, M., Hernández-Barrera, V., & Arendt-Nielsen, L. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11020413 · Cited by 303
Haitao, T., Vermunt, J. V., Abeykoon, J., Ghamrawi, R., Gunaratne, M., Jayachandran, M., Narang, K., Parashuram, S., Suvakov, S., & Garovic, V. D. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.07.024 · Cited by 297
Rahman, S., Montero, M. T. V., Rowe, K., Kirton, R., & Kunik, F. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1902303 · Cited by 289
ACE2/ADAM17/TMPRSS2 Interplay May Be the Main Risk Factor for COVID-19
Zipeto, D., Palmeira, J. D. F., Argañaraz, G. A., & Argañaraz, E. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.576745 · Cited by 267
D'cruz, M., & Banerjee, D. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113369 · Cited by 260
Ovsyannikova, I. G., Haralambieva, I. H., Crooke, S. N., Poland, G. A., & Kennedy, R. B. (2020) · Immunological Reviews · doi:10.1111/imr.12897 · Cited by 258
Pathophysiology of COVID-19: Mechanisms Underlying Disease Severity and Progression
Bohn, M. K., Hall, A., Sepiashvili, L., Jung, B., Steele, S., & Adeli, K. (2020) · Physiology · doi:10.1152/physiol.00019.2020 · Cited by 258
Acceptability of a COVID-19 Vaccine Among Healthcare Workers in the Kingdom of Saudi Arabia
Qattan, A. M. N., Alshareef, N., Alsharqi, O., Al Rahahleh, N., Chirwa, G. C., & Al-Hanawi, M. K. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.644300 · Cited by 255
Jaywant, A., Vanderlind, W. M., Alexopoulos, G. S., Fridman, C. B., Perlis, R. H., & Gunning, F. M. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-00978-8 · Cited by 248
“differences in COVID-19 infection [32, 33].”
Vahidy, F. S., Pan, A. P., Ahnstedt, H., Munshi, Y., Choi, H. A., Tiruneh, Y., Nasir, K., Kash, B. A., Andrieni, J. D., & McCullough, L. D. (2021) · PLOS ONE · doi:10.1371/journal.pone.0245556 · Cited by 231
Addressing the mental health impact of COVID-19 through population health
Boden, M., Zimmerman, L., Azevedo, K. J., Ruzek, J. I., Gala, S., Abdel Magid, H. S., Cohen, N., Walser, R., Mahtani, N. D., Hoggatt, K. J., et al. (2021) · Clinical Psychology Review · doi:10.1016/j.cpr.2021.102006 · Cited by 216
Sex differential in COVID-19 mortality varies markedly by age
Bhopal, S. S., & Bhopal, R. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31748-7 · Cited by 203
Gender inequalities during COVID-19
Fisher, A. N., & Ryan, M. K. (2021) · Group Processes & Intergroup Relations · doi:10.1177/1368430220984248 · Cited by 189
Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly
Sachs, J. D., Abdool Karim, S., Aknin, L., Allen, J., Brosbøl, K., Cuevas Barron, G., Daszak, P., Espinosa, M. F., Gaspar, V., Gaviria, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31927-9 · Cited by 171
Sex and age differences in COVID-19 mortality in Europe
Ahrenfeldt, L. J., Otavova, M., Christensen, K., & Lindahl-Jacobsen, R. (2021) · Wiener klinische Wochenschrift · doi:10.1007/s00508-020-01793-9 · Cited by 160
Social inequalities and COVID-19 mortality in the city of São Paulo, Brazil
Ribeiro, K. B., Ribeiro, A. F., Veras, M. A. D. S. M., & de Castro, M. C. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab022 · Cited by 134
Bhargava, A., Arnold, A. P., Bangasser, D. A., Denton, K. M., Gupta, A., Hilliard Krause, L. M., Mayer, E. A., McCarthy, M., Miller, W. L., Raznahan, A., et al. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnaa034 · Cited by 130
Negrini, F., Ferrario, I., Mazziotti, D., Berchicci, M., Bonazzi, M., de Sire, A., Negrini, S., & Zapparoli, L. (2021) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2020.09.376 · Cited by 121
Bu, F., Bone, J. K., Mitchell, J. J., Steptoe, A., & Fancourt, D. (2021) · Scientific Reports · doi:10.1038/s41598-021-97065-1 · Cited by 114
Scully, E. P., Schumock, G., Fu, M., Massaccesi, G., Muschelli, J., Betz, J., Klein, E. Y., West, N. E., Robinson, M., Garibaldi, B. T., et al. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab448 · Cited by 73
“Immune responses are directly modified by sex steroids [19] and by sex-specific patterns of gene expression [20], which collectively contribute to differences in applyparastyle “fig//caption/p[1]” parastyle “FigCapt””
BackgroundAuvigne, V., Vaux, S., Strat, Y. L., Schaeffer, J., Fournier, L., Tamandjou, C., Montagnat, C., Coignard, B., Levy-Bruhl, D., & Parent du Châtelet, I. (2022) · eClinicalMedicine · doi:10.1016/j.eclinm.2022.101455 · Cited by 63
Ahmed-Hassan, H., Sisson, B., Shukla, R. K., Wijewantha, Y., Funderburg, N. T., Li, Z., Hayes, D., Demberg, T., & Liyanage, N. P. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01979 · Cited by 47
Rinderknecht, M. D., & Klopfenstein, Y. (2021) · npj Digital Medicine · doi:10.1038/s41746-021-00482-9 · Cited by 23
Gender equality and COVID-19: act now before it is too late
Morgan, R., Pimenta, D. N., & Rashid, S. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00278-1 · Cited by 16
Shahbazi, F., Karami, M., Mirzaei, M., & Mohammadi, Y. (2021) · Journal of Research in Health Sciences · doi:10.34172/jrhs.2021.47 · Cited by 6
Metadata
- Authors
- Jin, J.-M., Bai, P., He, W., Wu, F., Liu, X.-F., Han, D.-M., Liu, S., & Yang, J.-K.
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2020-04-29
- Volume
- 8
- Pages
- 152-152
- ISSN
- 2296-2565 (ISSN-L)
- OpenAlex
- W3020512604
- Cited by
- 2,325
- References
- 13
- FWCI
- 60.66
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.